Literature DB >> 18712049

Associations of hypertension and its complications with variations in the xanthine dehydrogenase gene.

Jin Yang1, Kei Kamide, Yoshihiro Kokubo, Shin Takiuchi, Takeshi Horio, Tetsutaro Matayoshi, Hisayo Yasuda, Yoshikazu Miwa, Masayoshi Yoshii, Fumiki Yoshihara, Satoko Nakamura, Hajime Nakahama, Hitonobu Tomoike, Toshiyuki Miyata, Yuhei Kawano.   

Abstract

Hyperuricemia and oxidative stress participate in the pathophysiology of hypertension and its complications. Xanthine dehydrogenase (XDH) produces urate and, in its oxidase isoform, reactive oxygen species. Here we have studied whether or not the genetic variations in XDH could be implicated in hypertension and its complications. By sequencing the promoter region and all exons of XDH in 48 subjects, we identified three missense mutations (G172R, A932T, N1109T) in a heterozygous state in addition to 34 variations, including 15 common single nucleotide polymorphisms (SNPs). The three missense mutations and eight common SNPs (11488C>G, 37387A>G, 44408A>G, 46774G>A, 47686C>T, 49245A>T, 66292C>G, and 69901A>C) were genotyped in 953 hypertensive Japanese subjects and in 1,818 subjects from a general Japanese population. Four hypertensive patients with rare missense mutations (G172R or N1109T) in homozygous form had severe hypertension. Multivariate logistic regression analysis showed a significant association of three SNPs with hypertension in men: 47686C>T (exon 22, odds ratio [OR]: 1.52, p = 0.047) and 69901A>C (intron 31, OR: 3.14, p = 0.039) in the recessive model, and 67873A>C (N1109T) (exon 31, OR: 1.84, p = 0.018) in the dominant model. After full adjustment for all confounding factors, only one polymorphism (69901A>C) was found to be associated with carotid atherosclerosis in the dominant model (p = 0.028). Multiple logistic regression analysis showed that one SNP (66292C>G) was significantly associated with chronic kidney disease (CKD: estimated creatinine clearance < 60 ml/min) in the recessive model (p = 0.0006). Our results suggest that genetic variations in XDH contribute partly to hypertension and its complications, including atherosclerosis and CKD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712049     DOI: 10.1291/hypres.31.931

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  14 in total

Review 1.  Hyperuricemia and Hypertension: Links and Risks.

Authors:  Douglas J Stewart; Valerie Langlois; Damien Noone
Journal:  Integr Blood Press Control       Date:  2019-12-24

2.  Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}.

Authors:  Sophie Gibbings; Nancy D Elkins; Hillary Fitzgerald; Janice Tiao; Mari E Weyman; Gayle Shibao; Mehdi A Fini; Richard M Wright
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

3.  Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.

Authors:  Matthew B Carroll; Derek M Smith; Thomas L Shaak
Journal:  Rheumatol Int       Date:  2016-10-31       Impact factor: 2.631

Review 4.  Oxidative stress and hypertension: current concepts.

Authors:  Ana M Briones; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 5.  Uric acid and hypertension: cause or effect?

Authors:  Marilda Mazzali; Mehmet Kanbay; Mark S Segal; Mohamed Shafiu; Diana Jalal; Daniel I Feig; Richard J Johnson
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

Review 6.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

7.  Gene polymorphism of vascular endothelial growth factor -1154 G>A is associated with hypertensive nephropathy in a Hispanic population.

Authors:  Jae Wook Yang; Ian V Hutchinson; Tariq Shah; Jianwen Fang; David I Min
Journal:  Mol Biol Rep       Date:  2010-11-16       Impact factor: 2.316

8.  Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: Linear mixed-effects model analyses.

Authors:  Kazuma Mori; Masato Furuhashi; Marenao Tanaka; Yukimura Higashiura; Masayuki Koyama; Nagisa Hanawa; Hirofumi Ohnishi
Journal:  Hypertens Res       Date:  2021-11-30       Impact factor: 3.872

Review 9.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

10.  Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.

Authors:  Theodora Szasz; Robert Patrick Davis; Hannah S Garver; Robert J Burnett; Gregory D Fink; Stephanie W Watts
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.